首页 > 文献资料
-
绝经后骨质疏松症的激素补充治疗
INTRODUCTIONEstrin attaches importance to development of skeleton and sustain of bone quantity.Level of estrin drops significantly after mentopause and rebuilding of bone loses balance.Absorption of bone is more than synthesis of bone and losing rate rate of bone fastens.The accelerated losing of bone occurs in the period of menstrual disorder perimenopausal period. To healthy worn, losing quantity of bone accounted for 3% to 10% on first year of menopause and 6% to 14%on second and third year.It is estimated that woman will lose 50%of bone quantity of lumbar vertebrae and 30% of bone quantity of corter, which was respectively 30% and 20% in man. The loss of skeleton after menopause occurs firetly at lumbar vertebrae and spongy bone in the end of long bone, which was often combined with changes of bonne structure Generally speaking,once bone quantity drops 10%, the risk of fracture adds one time.
-
围绝经期激素替代治疗骨质疏松症等问题的新观点
Hormone replacement therapy is carrying weight with the improvement of people's living standard. But its application is greatly limited because of side effects. Some new viewpoints have been put forward after study in a deep going way by domestic and foreign researchers.
-
女性围绝经期综合征的激素替代治疗
女性更年期是指女性因卵巢功能逐渐衰退、生殖器官开始萎缩而至月经终止的一段时间.由于更年期的定义含糊,1994年世界卫生组织(WHO)提出使用围绝经期一词.围绝经期是指从接近绝经出现与绝经有关的内分泌、生物学和临床特征起至绝经一年内的期间(即绝经过渡期至绝经后一年).绝经是指月经完全停止一年以上.
-
围绝经期女性抑郁症复发因素分析
据2002年世界卫生组织报告,抑郁症已成为世界第四大疾患.据预测从2010-2020年以致残水平和社会花费计算,抑郁症将仅次于缺血性心脏病,成为第二位疾病[1].
-
围绝经期激素替代疗法68例临床分析
对68例围绝经期妇女给予口服结合型雌激素(CE)治疗,以探讨激素替代疗法对围绝经期妇女的血清雌二醇(E2)、子宫内膜、阴道细胞学评分及更年期症状的影响,提高围绝经期妇女的生活质量.